People
Proteros names new executive board member, chief operating officer and chief financial officer of Proteros Biostructures
10 January 2018 -

Proteros, a Germany-based private biotech company, has named Dave Lemus as an executive board member, chief operating officer and chief financial officer of Proteros Biostructures, it was reported yesterday.

Lemus will also serve in the role of non-executive board chairman of Proteros USA. Prior to his new roles, he was chief operating officer and chief financial officer of Medigene, assisting in its transformation into an immunotherapy-based company through the establishment of strategic partnerships. He has also held roles with MorphoSys and Hoffman La Roche.

Torsten Neuefeind, chief executive officer of Proteros, said, 'I am delighted to have Dave on board during what is a phase of rapid development and progress at Proteros. We have greatly appreciated his contributions over the last years in his service on our board, and I sincerely believe he can support us in achieving our goal to become a global leader on technically challenging and novel targets.'

Login
Username:

Password: